Theresa Caruana
Datos Biográficos
| ID | 307283 |
|---|---|
| NOMBRE | Theresa Caruana |
| NOMBRES | Theresa |
| APELLIDO | Caruana |
| FIRMA | CARUANA T |
| AFILIACIONES | UNSW Sydney |
| ORCID | 0000-0003-1555-2775 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 19 |
| TOTAL DE CITAS | 41 |
| TOTAL COMO AUTOR | 19 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2016 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 2 |
Exploring the benefits and challenges of lived and living experience among support workers in the alcohol, drug and mental health workforce in Australia
Study examined the role of AOD and mental health workers with lived and living experience (LLE). • It assessed the organisational supports needed to sustain safe and effective practice. • Workers described benefits in relationship with client when disclosing LLE. • Care is needed to balance authenticity with professional boundaries and self-protection. • Meaningful inclusion of LLE requires full structural and organisational support for workers. …
Opioid agonist treatment and trust in the community pharmacy setting
Background: Opioid agonist treatment (OAT) in New South Wales Australia involves prescribed consumption of methadone or buprenorphine formulations and is commonly accessed through community pharmacies.People with a history of drug use often feel mistrusted and this can deter them from starting or staying in treatment.This study sought pharmacist and consumer perspectives to understand how treatment engagement can be best supported.Objective: To e…
A huge, unwieldy barrier to push through on a daily basis”
Understanding, responding to, and mitigating stigma need recognition as core aspects of AOD professional roles. To support worker retention and wellbeing, we suggest AOD services prioritise the development of strategies for working within a stigmatised context, while continuing to advocate against the injustices that stigma creates for people who use drugs
Medication safety, privacy, and stigma
Opioid agonist treatment (OAT) involves the daily consumption of long-acting opioid medications to assist in managing health and wellbeing issues related to illicit or high-strength opioid drug use. Flooding events disrupted OAT service systems in the Northern Rivers region (Australia) in 2022. This study describes the experiences of OAT consumers and pharmacists during this time, including how structural stigma may have limited clinician behavio…
Stigma by association among alcohol and other drug and harm reduction workers
Experiences of stigma and subsequent reduced access to health care among women who inject drugs
The gendered violence of injecting‐related stigma among relatively affluent, suburban women who inject drugs
Differences in stigma reduction related to injection drug use between people expressing conservative, moderate and progressive values following an online intervention
Quantifying stigma effects
Opioid agonist treatment (OAT) is subject to stigma due to its association with criminalized and socially discredited illicit drug use behaviors. This study aimed to explore if the negative effects of OAT stigma on consumer well-being could be quantified. It tested if the attitudes of OAT dispensing pharmacists toward people who take OAT (compared with other pharmacy customers) could predict their OAT customers’ well-being over time and if consum…
Reducing stigma within pharmacy opioid agonist treatment encounters
Although community pharmacies are the primary site for opioid agonist treatment (OAT) dispensing in Australia, little is known about the service experiences of consumers and pharmacists. This study aimed to explore how OAT consumers experienced social inclusion and stigma in this setting, and how pharmacists can dispense OAT in ways that minimise perceived, enacted, and felt stigma. Semi-structured interviews were undertaken with fifteen consumer…
Injection drug use in an affluent beachside community in Sydney
Factors associated with sharing equipment among people who inject drugs
Perceptions of Covid-19 Vaccines
COVID-19 vaccination is particularly challenging among populations who have experienced discrimination in healthcare settings. This paper presents qualitative findings from in-depth interviews about COVID-19 vaccination conducted in Australia between October 2020 and November 2021. Data from four different studies are presented; each population has unique experiences of discrimination within the healthcare system: Aboriginal people; people who in…
Grew Up with a Silver Spoon in My Mouth, But it Ended Up the Nose
Criminological scholarship has long grappled with the roles that stigma and labelling play in drug use in disadvantaged communities. While stigma leads to marginalisation, less is known about the way stigma impacts the structurally advantaged, or those from communities of relative affluence. Our research involved fieldwork and 18 qualitative interviews with people who inject drugs in the affluent coastal community of Sydney’s Northern Beaches. We…
Practising care in a pandemic
From the outset of the COVID-19 pandemic, fears have been raised worldwide regarding the unique challenges facing socially marginalised people such as those who inject drugs. This article draws on in-depth interviews conducted during the first year of the pandemic with people who inject drugs living in urban and regional Australia. Perhaps the most surprising finding to emerge was the number of participants who reported minimal disruption to thei…
Optimising community health services in Australia for populations affected by stigmatised infections
Stigma in health services undermines diagnosis, treatment and successful health outcomes for all communities, but especially for those affected by blood-borne viruses and sexually transmitted infections (STIs). This study sought to examine experiences in accessing and receiving health services, including what characteristics promoted better health, safety and well-being for people with blood-borne viruses or STIss. It conducted 46 in-depth interv…
Health worker perceptions of the impact of Covid‐19 on harm reduction services for people who inject drugs
The COVID-19 pandemic has affected entire systems of health service provision globally, including health service closure, redeployment of staff and resources and implementation of infection prevention protocols. Harm reduction facilities face particular challenges responding to COVID-19, attempting to continue service provision to people who inject drugs with minimal service disruption whilst protecting their staff. This research assessed the imp…
Sexual Difficulties, Problems, and Help-Seeking in a National Representative Sample
A Profile of Pornography Users in Australia
There are societal concerns that looking at pornography has adverse consequences among those exposed. However, looking at sexually explicit material could have educative and relationship benefits. This article identifies factors associated with looking at pornography ever or within the past 12 months for men and women in Australia, and the extent to which reporting an "addiction" to pornography is associated with reported bad effects. Data from t…
A Profile of Pornography Users in Australia
There are societal concerns that looking at pornography has adverse consequences among those exposed. However, looking at sexually explicit material could have educative and relationship benefits. This article identifies factors associated with looking at pornography ever or within the past 12 months for men and women in Australia, and the extent to which reporting an "addiction" to pornography is associated with reported bad effects. Data from t…
Practising care in a pandemic
From the outset of the COVID-19 pandemic, fears have been raised worldwide regarding the unique challenges facing socially marginalised people such as those who inject drugs. This article draws on in-depth interviews conducted during the first year of the pandemic with people who inject drugs living in urban and regional Australia. Perhaps the most surprising finding to emerge was the number of participants who reported minimal disruption to thei…
Sexual Difficulties, Problems, and Help-Seeking in a National Representative Sample
Grew Up with a Silver Spoon in My Mouth, But it Ended Up the Nose
Criminological scholarship has long grappled with the roles that stigma and labelling play in drug use in disadvantaged communities. While stigma leads to marginalisation, less is known about the way stigma impacts the structurally advantaged, or those from communities of relative affluence. Our research involved fieldwork and 18 qualitative interviews with people who inject drugs in the affluent coastal community of Sydney’s Northern Beaches. We…
Health worker perceptions of the impact of Covid‐19 on harm reduction services for people who inject drugs
The COVID-19 pandemic has affected entire systems of health service provision globally, including health service closure, redeployment of staff and resources and implementation of infection prevention protocols. Harm reduction facilities face particular challenges responding to COVID-19, attempting to continue service provision to people who inject drugs with minimal service disruption whilst protecting their staff. This research assessed the imp…
A Profile of Pornography Users in Australia
There are societal concerns that looking at pornography has adverse consequences among those exposed. However, looking at sexually explicit material could have educative and relationship benefits. This article identifies factors associated with looking at pornography ever or within the past 12 months for men and women in Australia, and the extent to which reporting an "addiction" to pornography is associated with reported bad effects. Data from t…
Optimising community health services in Australia for populations affected by stigmatised infections
Stigma in health services undermines diagnosis, treatment and successful health outcomes for all communities, but especially for those affected by blood-borne viruses and sexually transmitted infections (STIs). This study sought to examine experiences in accessing and receiving health services, including what characteristics promoted better health, safety and well-being for people with blood-borne viruses or STIss. It conducted 46 in-depth interv…
Health worker perceptions of the impact of Covid‐19 on harm reduction services for people who inject drugs
The COVID-19 pandemic has affected entire systems of health service provision globally, including health service closure, redeployment of staff and resources and implementation of infection prevention protocols. Harm reduction facilities face particular challenges responding to COVID-19, attempting to continue service provision to people who inject drugs with minimal service disruption whilst protecting their staff. This research assessed the imp…
Sexual Difficulties, Problems, and Help-Seeking in a National Representative Sample
Injection drug use in an affluent beachside community in Sydney
Factors associated with sharing equipment among people who inject drugs
Perceptions of Covid-19 Vaccines
COVID-19 vaccination is particularly challenging among populations who have experienced discrimination in healthcare settings. This paper presents qualitative findings from in-depth interviews about COVID-19 vaccination conducted in Australia between October 2020 and November 2021. Data from four different studies are presented; each population has unique experiences of discrimination within the healthcare system: Aboriginal people; people who in…
Grew Up with a Silver Spoon in My Mouth, But it Ended Up the Nose
Criminological scholarship has long grappled with the roles that stigma and labelling play in drug use in disadvantaged communities. While stigma leads to marginalisation, less is known about the way stigma impacts the structurally advantaged, or those from communities of relative affluence. Our research involved fieldwork and 18 qualitative interviews with people who inject drugs in the affluent coastal community of Sydney’s Northern Beaches. We…
Practising care in a pandemic
From the outset of the COVID-19 pandemic, fears have been raised worldwide regarding the unique challenges facing socially marginalised people such as those who inject drugs. This article draws on in-depth interviews conducted during the first year of the pandemic with people who inject drugs living in urban and regional Australia. Perhaps the most surprising finding to emerge was the number of participants who reported minimal disruption to thei…
Medication safety, privacy, and stigma
Opioid agonist treatment (OAT) involves the daily consumption of long-acting opioid medications to assist in managing health and wellbeing issues related to illicit or high-strength opioid drug use. Flooding events disrupted OAT service systems in the Northern Rivers region (Australia) in 2022. This study describes the experiences of OAT consumers and pharmacists during this time, including how structural stigma may have limited clinician behavio…
Stigma by association among alcohol and other drug and harm reduction workers
Experiences of stigma and subsequent reduced access to health care among women who inject drugs
The gendered violence of injecting‐related stigma among relatively affluent, suburban women who inject drugs
Differences in stigma reduction related to injection drug use between people expressing conservative, moderate and progressive values following an online intervention
Quantifying stigma effects
Opioid agonist treatment (OAT) is subject to stigma due to its association with criminalized and socially discredited illicit drug use behaviors. This study aimed to explore if the negative effects of OAT stigma on consumer well-being could be quantified. It tested if the attitudes of OAT dispensing pharmacists toward people who take OAT (compared with other pharmacy customers) could predict their OAT customers’ well-being over time and if consum…
Reducing stigma within pharmacy opioid agonist treatment encounters
Although community pharmacies are the primary site for opioid agonist treatment (OAT) dispensing in Australia, little is known about the service experiences of consumers and pharmacists. This study aimed to explore how OAT consumers experienced social inclusion and stigma in this setting, and how pharmacists can dispense OAT in ways that minimise perceived, enacted, and felt stigma. Semi-structured interviews were undertaken with fifteen consumer…
Opioid agonist treatment and trust in the community pharmacy setting
Background: Opioid agonist treatment (OAT) in New South Wales Australia involves prescribed consumption of methadone or buprenorphine formulations and is commonly accessed through community pharmacies.People with a history of drug use often feel mistrusted and this can deter them from starting or staying in treatment.This study sought pharmacist and consumer perspectives to understand how treatment engagement can be best supported.Objective: To e…
A huge, unwieldy barrier to push through on a daily basis”
Understanding, responding to, and mitigating stigma need recognition as core aspects of AOD professional roles. To support worker retention and wellbeing, we suggest AOD services prioritise the development of strategies for working within a stigmatised context, while continuing to advocate against the injustices that stigma creates for people who use drugs
Exploring the benefits and challenges of lived and living experience among support workers in the alcohol, drug and mental health workforce in Australia
Study examined the role of AOD and mental health workers with lived and living experience (LLE). • It assessed the organisational supports needed to sustain safe and effective practice. • Workers described benefits in relationship with client when disclosing LLE. • Care is needed to balance authenticity with professional boundaries and self-protection. • Meaningful inclusion of LLE requires full structural and organisational support for workers. …
Psychology (16 obras) · Medicine (14 obras) · Psychiatry (13 obras) · HIV, Drug Use, Sexual Risk (12 obras) · Family medicine (8 obras) · Political science (7 obras) · Social Psychology (7 obras) · Nursing (6 obras) · Sociology (6 obras) · Clinical Psychology (5 obras)